Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer. Breast Cancer Res Treat. 2011 May; 127(1):153-62.